Inlive (enterovirus type 71 vaccine（Vero Cell), inactivated) / Sinovac  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlive (enterovirus type 71 vaccine（Vero Cell), inactivated) / Sinovac
NCT01421121: Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants

Completed
2
540
RoW
100U EV71 vaccine with adjuvant, EV71 vaccine, 200 U EV71 vaccine with adjuvant, 400U EV71 vaccine with adjuvant, 200U EV71 vaccine without adjuvant, Placebo
Sinovac Biotech Co., Ltd
Infection, Viral, Enterovirus
09/11
12/11
NCT01812135: Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants

Withdrawn
2
0
RoW
400 U EV71 vaccine with adjuvant, EV71 vaccine
Sinovac Biotech Co., Ltd
Infection, Viral, Enterovirus
11/11
12/11
NCT04467541: Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months

Completed
1/2
430
RoW
Inactivated Enterovirus Type 71 (EV71) Vaccine (Vero Cell), Inlive
International Centre for Diarrhoeal Disease Research, Bangladesh
Hand Foot & Mouth Disease
01/20
01/20
NCT06063057: Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Recruiting
1/2
744
RoW
low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, Enterovirus type EV71 vaccine (Vero cell), Inactivated
Sinovac Biotech Co., Ltd
Hand, Foot and Mouth Disease, Herpangina
12/24
04/25

Download Options